Preliminary Results of Utrasound-Guided Percutaneous Radiofrequency Ablation in the Treatment of Refractory Non-nodular Hyperthyroidism

Smith TJ, Hegedus L. Graves’ disease. N Engl J Med. 2016;375(16):1552–65.

Article  PubMed  Google Scholar 

Nystrom HF, Jansson S, Berg G. Incidence rate and clinical features of hyperthyroidism in a long-term iodine sufficient area of Sweden (Gothenburg) 2003–2005. Clin Endocrinol (Oxf). 2013;78(5):768–76.

Article  PubMed  Google Scholar 

Ross DS, Burch HB, Cooper DS, et al. 2016 American thyroid association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid. 2016;26(10):1343–421.

Article  PubMed  Google Scholar 

Bahn Chair RS, Burch HB, Cooper DS, et al. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American thyroid association and American association of clinical endocrinologists. Thyroid. 2011;21(6):593–646.

Article  PubMed  Google Scholar 

Abraham P, Avenell A, McGeoch SC, et al. Antithyroid drug regimen for treating Graves’ hyperthyroidism. Cochrane Database Syst Rev. 2010. https://doi.org/10.1002/14651858.CD003420.pub4/abstract.

Article  PubMed  PubMed Central  Google Scholar 

Marcocci C, Watt T, Altea MA, et al. Fatal and non-fatal adverse events of glucocorticoid therapy for Graves’ orbitopathy: a questionnaire survey among members of the European thyroid association. Eur J Endocrinol. 2012;166(2):247–53.

Article  CAS  PubMed  Google Scholar 

Walasik-Szemplinska D, Kaminski G, Sudol-Szopinska I. Life-threatening complications of high doses of intravenous methylprednisolone for treatment of Graves’ orbitopathy. Thyroid Res. 2019;12:13.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cepkova J, Horacek J, Vizda J, et al. Radioiodine treatment of Graves’ disease—dose/response analysis. Acta Medica (Hradec Kralove). 2014;57(2):49–55.

Article  CAS  PubMed  Google Scholar 

Bojic T, Paunovic I, Diklic A, et al. Total thyroidectomy as a method of choice in the treatment of graves ‘disease—analysis of 1432 patients. BMC Surg. 2015;15:39.

Article  PubMed  PubMed Central  Google Scholar 

Nwatsock JF, Taieb D, Tessonnier L, et al. Radioiodine thyroid ablation in Graves’ hyperthyroidism: merits and pitfalls. World J Nucl Med. 2012;11(1):7–11.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Reid JR, Wheeler SF. Hyperthyroidism: diagnosis and treatment. Am Fam Physician. 2005;72(4):623–30.

PubMed  Google Scholar 

Ginsberg J. Diagnosis and management of Graves’ disease. CMAJ. 2003;168(5):575–85.

PubMed  PubMed Central  Google Scholar 

Chen DY, Schneider PF, Zhang XS, et al. Striving for euthyroidism in radioiodine therapy of Graves’ disease: a 12 year prospective, randomized, open-label blinded end point study. Thyroid. 2011;21(6):647–54.

Article  CAS  PubMed  Google Scholar 

Berber E, Bernet V, Fahey TJ, et al. American thyroid association statement on remote-access thyroid surgery. Thyroid. 2016;26(3):331–7.

Article  PubMed  PubMed Central  Google Scholar 

Jeong WK, Baek JH, Rhim H, et al. Radiofrequency ablation of benign thyroid nodules: safety and imaging follow-up in 236 patients. Eur Radiol. 2008;18(6):1244–50.

Article  PubMed  Google Scholar 

Baek JH, Kim YS, Lee D, et al. Benign predominantly solid thyroid nodules: prospective study of efficacy of sonographically guided radiofrequency ablation versus control condition. AJR Am J Roentgenol. 2010;194(4):1137–42.

Article  PubMed  Google Scholar 

Monchik JM, Donatini G, Iannuccilli J, et al. Radiofrequency ablation and percutaneous ethanol injection treatment for recurrent local and distant well-differentiated thyroid carcinoma. Ann Surg. 2006;244(2):296–304.

Article  PubMed  PubMed Central  Google Scholar 

Tang X, Cui D, Chi J, et al. Evaluation of the safety and efficacy of radiofrequency ablation for treating benign thyroid nodules. J Cancer. 2017;8(5):754–60.

Article  PubMed  PubMed Central  Google Scholar 

Kim HJ, Cho SJ, Baek JH, et al. Efficacy and safety of thermal ablation for autonomously functioning thyroid nodules: a systematic review and meta-analysis. Eur Radiol. 2021;31(2):605–15.

Article  PubMed  Google Scholar 

Na DG, Lee JH, Jung SL, et al. Radiofrequency ablation of benign thyroid nodules and recurrent thyroid cancers: consensus statement and recommendations. Korean J Radiol. 2012;13(2):117–25.

Article  PubMed  PubMed Central  Google Scholar 

Chen Y, Liang L, Fang Y, et al. Iodine 131 joint radio frequency ablation treatment for child with hyperthyroidism goiter: one case report. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2017;46(1):89–91.

CAS  PubMed  Google Scholar 

Zhu JE, Zhang HL, Yu SY, et al. US-guided percutaneous microwave ablation for hyperthyroidism and immediate treatment response evaluation with contrast-enhanced ultrasound. Clin Hemorheol Microcirc. 2021;79(3):435–44.

Article  CAS  PubMed  Google Scholar 

Xiaoyin T, Ping L, Dan C, et al. Risk assessment and hydrodissection technique for radiofrequency ablation of thyroid benign nodules. J Cancer. 2018;9(17):3058–66.

Article  PubMed  PubMed Central  Google Scholar 

Sacks D, McClenny TE, Cardella JF, et al. Society of interventional radiology clinical practice guidelines. J Vasc Interv Radiol. 2003;14(9 Pt 2):S199-202.

Article  PubMed  Google Scholar 

留言 (0)

沒有登入
gif